Skip to main content
RPbio Inc. logo

RPbio Inc. — Investor Relations & Filings

Ticker · 314140 ISIN · KR7314140005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 314140

About RPbio Inc.

https://rpbio.co.kr/html/en/main.php

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서” covering the period 2026.01.01–2026.03.31 (Korean quarterly report). It contains detailed financial tables, business overview, capital changes, production data, risk management, etc., which are substantive interim/quarterly financial disclosures, not merely an announcement. This matches our definition of an Interim/Quarterly Report (Code: IR). Q1 2026
2026-05-15 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a formal notification to the Financial Services Commission and Korea Exchange regarding the appointment, re-appointment, dismissal, or mid-term resignation of an outside director (사외이사). It includes details such as change date, number of directors, pre- and post-change director counts and ratios, and specific information about the newly appointed or re-appointed outside director. This matches the definition of a Board/Management Information filing (announcements of changes in the company’s board of directors or senior management).
2026-04-01 Korean
대표이사변경
Board/Management Information Classification · 92% confidence The document is a corporate disclosure announcing a change in the company’s representative director (CEO) – it outlines the before/after officers, reasons for the change, dates of board resolution, and related details. This clearly falls under a Board/Management Information filing, which covers announcements of changes in senior management.
2026-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “정기주주총회결과” and provides detailed voting outcomes on shareholder resolutions at the annual general meeting, including approval of financial statements, dividend resolution, and director appointments with voting percentages. It clearly announces the results of shareholder votes. Therefore, it fits the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-03-31 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is titled '사업보고서' (Business Report) for the 10th fiscal year (2025), which is the Korean equivalent of an Annual Report (10-K). It contains comprehensive company information, financial data, management discussion, and operational details for the full fiscal year. It is not an announcement or a summary, but the full report itself. FY 2025
2026-03-23 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.